240 results on '"Ronchi, Cristina L"'
Search Results
2. Coincidence of primary adrenocortical carcinoma and melanoma: three CASE reports
3. Urine steroid metabolomics for the differential diagnosis of adrenal incidentalomas in the EURINE-ACT study: a prospective test validation study
4. Primary unilateral macronodular adrenal hyperplasia with concomitant glucocorticoid and androgen excess and KDM1A inactivation.
5. Single‐nucleus and spatial transcriptome reveal adrenal homeostasis in normal and tumoural adrenal glands.
6. Next-generation therapies for adrenocortical carcinoma
7. Genomic and sequence variants of protein kinase A regulatory subunit type 1β (PRKAR1B) in patients with adrenocortical disease and Cushing syndrome
8. cAMP/protein kinase A signalling pathway and adrenocortical adenomas
9. Circulating cell-free DNA-based biomarkers for prognostication and disease monitoring in adrenocortical carcinoma.
10. Patterns of Lymph Node Recurrence in Adrenocortical Carcinoma: Possible Implications for Primary Surgical Treatment
11. Adrenocortical incidentalomas and bone: from molecular insights to clinical perspectives
12. Pheochromocytomas Most Commonly Present As Adrenal Incidentalomas: A Large Tertiary Center Experience.
13. Inflammation-based scores in benign adrenocortical tumours are linked to the degree of cortisol excess: a retrospective single-centre study.
14. Performance of DNA-based biomarkers for classification of adrenocortical carcinoma: a prognostic study.
15. Linsitinib (OSI-906) versus placebo for patients with locally advanced or metastatic adrenocortical carcinoma: a double-blind, randomised, phase 3 study
16. Adrenal disorders: Is there Any role for vitamin D?
17. Does vitamin D play a role in autoimmune endocrine disorders? A proof of concept
18. Gemcitabine-Based Chemotherapy in Adrenocortical Carcinoma: A Multicenter Study of Efficacy and Predictive Factors
19. Correction to: Adrenocortical incidentalomas and bone: from molecular insights to clinical perspectives
20. COVID‐19‐related adrenal haemorrhage: Multicentre UK experience and systematic review of the literature.
21. Recurrent EZH1 mutations are a second hit in autonomous thyroid adenomas
22. Role of Endocrine Gland-Derived Vascular Endothelial Growth Factor (EG-VEGF) and Its Receptors in Adrenocortical Tumors
23. Approach to the Patient With Adrenal Hemorrhage.
24. Inflammation-based scores as predictors of treatment response in advanced adrenocortical carcinoma.
25. Adrenocortical tumors and insulin resistance: What is the first step?
26. Mitotane Inhibits Sterol-O-Acyl Transferase 1 Triggering Lipid-Mediated Endoplasmic Reticulum Stress and Apoptosis in Adrenocortical Carcinoma Cells
27. Targeted Gene Expression Profile Reveals CDK4 as Therapeutic Target for Selected Patients With Adrenocortical Carcinoma
28. Expression of LIN28 and its regulatory microRNAs in adult adrenocortical cancer
29. Major Prognostic Role of Ki67 in Localized Adrenocortical Carcinoma After Complete Resection
30. ENSAT Registry-Based Randomized Clinical Trials for Adrenocortical Carcinoma
31. Prognostic Role of Targeted Methylation Analysis in Paraffin-embedded Samples of Adrenocortical Carcinoma.
32. The role of molecular profiling in adrenocortical carcinoma.
33. PKA Cα subunit mutation triggers caspase-dependent RIIβ subunit degradation via Ser\(^{114}\) phosphorylation
34. Differential expression of the protein kinase A subunits in normal adrenal glands and adrenocortical adenomas
35. Constitutive Activation of PKA Catalytic Subunit in Adrenal Cushingʼs Syndrome
36. MicroRNAs and Long Non-Coding RNAs in Adrenocortical Carcinoma.
37. Impact of the Chemokine Receptors CXCR4 and CXCR7 on Clinical Outcome in Adrenocortical Carcinoma
38. Evaluation of insulin resistance in acromegalic patients before and after treatment with somatostatin analogues
39. Low SGK1 Expression in Human Adrenocortical Tumors Is Associated with ACTH-Independent Glucocorticoid Secretion and Poor Prognosis
40. GH Replacement Improves Quality of Life and Metabolic Parameters in Cured Acromegalic Patients with Growth Hormone Deficiency
41. d3-Growth hormone receptor polymorphism in acromegaly: effects on metabolic phenotype
42. ERCC1 as predictive biomarker to platinum-based chemotherapy in adrenocortical carcinomas
43. Efficacy and tolerability of gamma knife radiosurgery in acromegaly: a 10-year follow-up study
44. Steroid Sulfation in Adrenal Tumors.
45. Effect of growth hormone deficiency and recombinant hGH (rhGH) replacement on the hypothalamic–pituitary–adrenal axis in children with idiopathic isolated GH deficiency
46. Adequacy of current postglucose GH nadir limit (< 1 μg/l) to define long-lasting remission of acromegalic disease
47. Effect of recombinant hGH (rhGH) replacement on gonadal function in male patients with organic adult-onset GH deficiency
48. Comparison between Six-Year Therapy with Long-Acting Somatostatin Analogs and Successful Surgery in Acromegaly: Effects on Cardiovascular Risk Factors
49. Long-Term Evaluation of Postoperative Acromegalic Patients in Remission with Previous and Newly Proposed Criteria
50. Effects of Modified Sham Feeding on Ghrelin Levels in Healthy Human Subjects
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.